Business Description
Ocugen Inc
NAICS : 325412
SIC : 2834
ISIN : US67577C1053
Compare
Compare
Traded in other countries / regions
OCGN.USA2H51.GermanyOCGN.Mexico IPO Date
2014-12-03Description
Ocugen Inc is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing gene therapies to cure blindness diseases and developing a vaccine to save lives from COVID-19. The breakthrough modifier gene therapy platform has the potential to treat multiple retinal diseases with one drug one to many and novel biologic product candidate aims to offer better therapy to patients with underserved diseases such as wet age-related macular degeneration, diabetic macular edema and diabetic retinopathy. The company is co-developing Bharat Biotech's COVAXIN vaccine candidate for COVID-19 in the U.S. and Canadian markets.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 10.74 | |||||
| Equity-to-Asset | 0.79 | |||||
| Debt-to-Equity | 0.09 | |||||
| Debt-to-EBITDA | -0.08 | |||||
| Interest Coverage | N/A |
N/A
|
N/A
| |||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 33.3 | |||||
| 3-Year EPS without NRI Growth Rate | 36.2 | |||||
| 3-Year FCF Growth Rate | 37.2 | |||||
| 3-Year Book Growth Rate | 21.9 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 50.39 | |||||
| 9-Day RSI | 41.38 | |||||
| 14-Day RSI | 39.31 | |||||
| 6-1 Month Momentum % | -48.45 | |||||
| 12-1 Month Momentum % | -74.89 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.46 | |||||
| Quick Ratio | 5.46 | |||||
| Cash Ratio | 5.24 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -61.5 | |||||
| Shareholder Yield % | -44.78 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROE % | -94.74 | |||||
| ROA % | -77.08 | |||||
| ROIC % | -638.35 | |||||
| ROC (Joel Greenblatt) % | -1328.84 | |||||
| ROCE % | -94.95 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PB Ratio | 1.51 | |||||
| Price-to-Tangible-Book | 1.51 | |||||
| EV-to-EBIT | -0.45 | |||||
| EV-to-EBITDA | -0.45 | |||||
| EV-to-Forward-Revenue | 3.65 | |||||
| EV-to-FCF | -0.51 | |||||
| Price-to-Net-Current-Asset-Value | 1.94 | |||||
| Price-to-Net-Cash | 2.03 | |||||
| Earnings Yield (Greenblatt) % | -222.22 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:OCGN
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Ocugen Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | |||
| EPS (TTM) ($) | -0.37 | ||
| Beta | 4.75 | ||
| Volatility % | 58.04 | ||
| 14-Day RSI | 39.31 | ||
| 14-Day ATR ($) | 0.021002 | ||
| 20-Day SMA ($) | 0.418335 | ||
| 12-1 Month Momentum % | -74.89 | ||
| 52-Week Range ($) | 0.39 - 2.0888 | ||
| Shares Outstanding (Mil) | 256.49 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Ocugen Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Ocugen Inc Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Ocugen Inc Frequently Asked Questions
What is Ocugen Inc(OCGN)'s stock price today?
The current price of OCGN is $0.41. The 52 week high of OCGN is $2.09 and 52 week low is $0.39.
When is next earnings date of Ocugen Inc(OCGN)?
The next earnings date of Ocugen Inc(OCGN) is 2023-11-08 Est..
Does Ocugen Inc(OCGN) pay dividends? If so, how much?
Ocugen Inc(OCGN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers